drugset / Trial / NCT05215158
Intravenous Versus Peribulbar Dexmedetomidine for Strabismus Surgery in Adults
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Using various adjuvants has become a trend in regional anesthesia practice to improve the quality of anesthesia and prolong postoperative analgesia. Dexmedetomidine, an alpha-2 agonist has been proposed as a safe and effective adjunct capable of extending the duration of the single-shot block
Timeline
- Start
- 2022-01-28
- Primary completion
- 2023-07-01
- Completion
- 2023-09-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dexmedetomidine | Other / unclassified | 50 ug | Intravenous |